The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma-Reference-Cited by-同舟云学术

The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma

Published:1995-06 Issue:2 Volume:176 Page:167-173
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Salter Janine,Maclennan Kenneth A.,Moore Jaqualyn,Dadian Grace,Riches Pamela G.,Gore Martin E.

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference16 articles.

1. Long term culture of tumour-specific cytotoxic T cells

2. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

3. A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

4. Immunohistological relation between DR antigen expression on melanoma cells and infiltration by CD8 + T cells

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma Modulates Intratumoral CD4/CD8 Ratio and Tumor Microenvironment: A Multicenter Phase II Clinical Trial;Journal of Clinical Oncology;2005-05-20

2. The Effect of Leukocyte Interleukin Injection (Multikine??) Treatment on the Peritumoral and Intratumoral Subpopulation of Mononuclear Cells and on Tumor Epithelia: A Possible New Approach to Augmenting Sensitivity to Radiation Therapy and Chemotherapy in Oral Cancer???A Multicenter Phase I/II Clinical Trial;The Laryngoscope;2003-12

3. Gene therapy for head and neck cancer;Surgical Oncology Clinics of North America;2002-07

4. IL-2 Gentherapie bei HNO-Karzinomen;Laryngo-Rhino-Otologie;2001-04

5. Lymphoid Cell Infiltration into Epstein-Barr Virus-positive Nasopharyngeal Carcinomas;Otolaryngology–Head and Neck Surgery;2001-02